FindTrial
Sign In

The risk trajectories of perioperative cognitive disorders after SARS-CoV-2 infection

The risk trajectories of perioperative cognitive disorders after SARS-CoV-2 infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068888
Enrollment
Unknown
Registered
2023-03-01
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative neurocognitive dysfunction

Interventions

positive SARS-CoV-2 infection:none
negative SARS-CoV-2 infection:none

Sponsors

Xuzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) over 18 years of age; (2) Patients undergoing elective surgery

Exclusion criteria

Exclusion criteria: (1) ASA classification > 3 (2) Fever, upper respiratory tract infection, lung infection; (3) severe SARS-CoV-2 infection (4) Cardiac surgery or neurosurgery (5) Received systematic chemotherapy 6 weeks before surgery (6) infected with SARS-CoV-2 before December 8, 2022

Design outcomes

Primary

MeasureTime frame
delirium;delayed neurocognitve recovery;postoperative neurocognitiv disorders;—

Countries

China

Contacts

Public ContactWang Liwei

Xuzhou Central Hospital

doctorlww@sina.com+86 189 5217 0255

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026